Langerhans cell histiocytosis (LCH) is an inflammatory neoplasia of myeloid precursor cells
driven by mutations in the mitogen-activated protein kinase pathway. When disease involves …

Objectives To review a single center outcome of patients with Langerhans Cell Histiocytosis
diagnosed at a tertiary referral hospital from Turkey. Methods: The files between 1989 and …

Background: Disease reactivation/refractory remains a major challenge in managing
Langerhans cell histiocytosis (LCH). Outcomes and late sequelae should be explored …

摘要目的: 探讨观察儿童朗格汉斯细胞组织增生症临床治疗方案和效果. 方法: 选取我院2007 年4
月-2014 年11 月收治的儿童朗格汉斯细胞组织细胞增生症65 例, 按随机数字表法分为观察组 …

Histiocytosis is a term applied to a group of rare disorders of the reticuloendothelial system.
Eosinophilic granuloma is the most benign and localized of the three Langerhans cell …

Histiocytosis is a term applied to a group of rare disorders of the reticuloendothelial system.
Eosinophilic granuloma is the most benign and localized of the three Langerhans cell …

Histiocytosis is a term applied to a group of rare disorders of the reticuloendothelial system.
Eosinophilic granuloma is the most benign and localized of the three Langerhans cell …